Cipla Ltd (CIPLA):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Cipla Ltd (CIPLA) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7160
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cipla Ltd (Cipla) is a pharmaceutical company, which manufactures and distributes branded medicines, generics and active pharmaceutical ingredients (APIs). It offers products for the treatment of various conditions such as cardiovascular and pediatric diseases, dermatological and cosmetological conditions, HIV/AIDS, diabetes, hepatitis, infectious diseases and critical care, malaria, cancer, neurological, ophthalmic, respiratory and urological conditions, osteoporosis and women’s health. The company also operates in consumer healthcare and biosimilar businesses. Cipla also manufactures metered-dose inhaler devices, spacers and related devices; and conducts R&D to develop new medicines and drug delivery systems. The company has operations in India, North America, South Africa and major regulated and emerging markets. Cipla is headquartered in Mumbai, Maharashtra, India.

Cipla Ltd (CIPLA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cipla Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cipla Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cipla Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cipla Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Cipla Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cipla Ltd, Medical Equipment, Deal Details 10
Private Equity 10
Cipla, Zydus Cadilla, Dr. Reddy’s Labs and Baring Asia May Acquire Bharat Serums and Vaccines 10
Partnerships 12
Cipla Enters into Distribution Agreement with BioQ Pharma 12
Cipla Enters into Co-Marketing Agreement with BioQuiddity for OneDose ReadyfusOR 13
Equity Offering 14
Cipla to Raise USD293.2 Million in Public Offering of Securities 14
Debt Offering 15
Cipla to Raise USD293.2 Million in Debt Offering 15
Acquisition 16
Cipla Acquires 60% Stake in Jay Precision Pharma for USD15.3 Million 16
Cipla Ltd – Key Competitors 17
Cipla Ltd – Key Employees 18
Cipla Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 22
Financial Announcements 22
Nov 07, 2017: Cipla Q2 FY18 Results Demonstrate Strong Growth Across Businesses and the Benefit of Operating Leverage 22
Aug 11, 2017: Cipla Announces Q1FY 18 Results 23
May 25, 2017: Cipla announces Q4 & FY 17 results Continued strong performance across key markets 24
Corporate Communications 25
Feb 08, 2017: Cipla Updates Appoints Mr. Mital Sanghvi To Senior Business Finance Role 25
Jan 09, 2017: Cipla appoints Peter Lankau as an Independent Director on its Board 26
Legal and Regulatory 27
Apr 16, 2018: Cipla: US FDA conducted a routine current Good Manufacturing Practices (cGMP) audit at its Indore formulations facility 27
Other Significant Developments 28
Jun 12, 2018: Cipla Quality Chemical Industries: Building capacity to mitigate the burden of cancer in Uganda 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Cipla Ltd, Medical Equipment, Key Facts, 2018 2
Cipla Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Cipla Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cipla Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cipla Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cipla Ltd, Deals By Market, 2012 to YTD 2018 8
Cipla Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cipla, Zydus Cadilla, Dr. Reddy’s Labs and Baring Asia May Acquire Bharat Serums and Vaccines 10
Cipla Enters into Distribution Agreement with BioQ Pharma 12
Cipla Enters into Co-Marketing Agreement with BioQuiddity for OneDose ReadyfusOR 13
Cipla to Raise USD293.2 Million in Public Offering of Securities 14
Cipla to Raise USD293.2 Million in Debt Offering 15
Cipla Acquires 60% Stake in Jay Precision Pharma for USD15.3 Million 16
Cipla Ltd, Key Competitors 17
Cipla Ltd, Key Employees 18
Cipla Ltd, Subsidiaries 19

List of Figures
Cipla Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Cipla Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Cipla Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Cipla Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Cipla Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cipla Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Cipla Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cipla Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Cipla Ltd (CIPLA):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kina Petroleum Ltd (KPL)-石油・ガス分野:企業M&A・提携分析
    Summary Kina Petroleum Limited (KPL) is an upstream oil and gas company that focuses on exploration, development and production activities. It has operations in Papua New Guinea (PNG) and Australia. The company focuses on participating in highly prospective oil and gas acreage positions near to prov …
  • Bonheur ASA (BON):企業の財務・戦略的SWOT分析
    Summary Bonheur ASA (Bonheur) is an oil and gas investment service provider that offers investment services for various energy sectors. The company invests in renewable energy, cruise, shipping and offshore wind, offshore drilling, and other investments. It operates shipping vessels for transport an …
  • Fujimori Kogyo Co., Ltd. (7917):企業の財務・戦略的SWOT分析
    Fujimori Kogyo Co., Ltd. (7917) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Ryanair Holdings plc:戦略・SWOT・企業財務分析
    Ryanair Holdings plc - Strategy, SWOT and Corporate Finance Report Summary Ryanair Holdings plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Public Joint-Stock Company Commercial Bank Privatbank:企業の戦略・SWOT・財務分析
    Public Joint-Stock Company Commercial Bank Privatbank - Strategy, SWOT and Corporate Finance Report Summary Public Joint-Stock Company Commercial Bank Privatbank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • Hansen Medical Inc (HNSN)-医療機器分野:企業M&A・提携分析
    Summary Hansen Medical Inc (Hansen Medical), formerly Autocath Inc, a subsidiary of Auris Surgical Robotics Inc, is a medical device company that develops, manufactures and markets magellan robotic system for peripheral vascular intervention. The company’s products include robotic system, robotic ca …
  • Maerki Baumann & Co. AG:企業の戦略・SWOT・財務情報
    Maerki Baumann & Co. AG - Strategy, SWOT and Corporate Finance Report Summary Maerki Baumann & Co. AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • PsiOxus Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary PsiOxus Therapeutics Ltd (PsiOxus), formerly known as Myotec Therapeutics Ltd is a drug company that develops novel therapeutics for cancer and other clinically unmet diseases. The company provides pipeline product portfolio such as an oncolytic vaccine and a dual action anabolic catabolic t …
  • Hawaiian Holdings, Inc.:企業の戦略・SWOT・財務分析
    Hawaiian Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hawaiian Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Capgemini SE:企業の戦略・SWOT・財務情報
    Capgemini SE - Strategy, SWOT and Corporate Finance Report Summary Capgemini SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • NanoString Technologies Inc (NSTG)-医療機器分野:企業M&A・提携分析
    Summary NanoString Technologies Inc (NanoString) is a provider of life science products and tools for translational research and molecular diagnostics. The company's products portfolio includes sprint profiler, Dx analysis system with flex, MAX analysis system, protein assays, solid tumor assays, ge …
  • Bahamas Petroleum Company Plc (BPC):石油・ガス:M&Aディール及び事業提携情報
    Summary Bahamas Petroleum Company Plc (Bahamas Petroleum), formerly BPC plc, is an oil and gas exploration company. The company invests in an offshore oil exploration programme in licence areas in the territorial waters and maritime Exclusive Economic Zone of The Bahamas. It holds interests in five …
  • Latin American Resources Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Latin American Resources Ltd (LAR) is an oil and gas company that offers exploration and development of natural resource properties for the production of oil and natural gas. The company's services include acquiring and developing oil and gas properties and its operational assets to achieve …
  • BT Group plc:企業の戦略・SWOT・財務情報
    BT Group plc - Strategy, SWOT and Corporate Finance Report Summary BT Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Belfius Bank Sa:企業の戦略・SWOT・財務分析
    Belfius Bank Sa - Strategy, SWOT and Corporate Finance Report Summary Belfius Bank Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Diehl Stiftung & Co. KG:企業の戦略・SWOT・財務情報
    Diehl Stiftung & Co. KG - Strategy, SWOT and Corporate Finance Report Summary Diehl Stiftung & Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • NuScale Power LLC:企業の戦略的SWOT分析
    NuScale Power LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • AZTherapies Inc-製薬・医療分野:企業M&A・提携分析
    Summary AZTherapies Inc (AZTherapies) is a clinical-stage drug development company, which focuses on the discovery, development and commercialization of medicines for the treatment of Alzheimer’s disease and other neuroinflammatory and neurodegenerative diseases. Its product pipeline includes the le …
  • Securitas AB (SECU B):企業の財務・戦略的SWOT分析
    Securitas AB (SECU B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • NanoString Technologies Inc (NSTG):医療機器:M&Aディール及び事業提携情報
    Summary NanoString Technologies Inc (NanoString) is a developer of life science tools for translational research and molecular diagnostics. The company's products include sprint profiler, Dx analysis system with flex, nCounter MAX analysis system, protein assays, solid tumor assays, gene fusion pane …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆